Highlights
- •Isolation precautions demand spending of a large amount of resources.
- •Multidrug-resistant gram-negative bacteria are the biggest challenge in our setting.
- •Benefits of screening and isolation must be balanced against resource utilization.
We aimed to describe the use of isolation beds between September 2011 and August 2013
at a tertiary hospital located in Southern Brazil. The main cause for isolation was
gram-negative carbapenem-resistant bacteria. Huge costs were associated with isolation
practices. Considering the high burden on the isolation ward, practice of surveillance
cultures and contact isolation should be balanced with other infection control practices.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Infection ControlAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings.Am J Infect Control. 2007; 35: S65-S164
- Isolation of NDM-producing Providencia rettgeri in Brazil.J Antimicrob Chemother. 2013; 68: 2956-2957
- Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil.Infection. 2009; 37: 474-476
- The challenges of antimicrobial resistance in Brazil.Clin Infect Dis. 2011; 52: 1138-1143
- Detection of OXA-370, an OXA-48-Related class D beta-lactamase, in Enterobacter hormaechei from Brazil.Antimicrob Agents Chemother. 2014; 58: 3566-3567
- SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.Infect Control Hosp Epidemiol. 2003; 24: 362-386
- Management of multidrug-resistant organisms in health care settings, 2006.Am J Infect Control. 2007; 35: S165-S193
- Adverse effects of isolation in hospitalised patients: a systematic review.J Hosp Infect. 2010; 76: 97-102
- Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.Intensive Care Med. 2013; 39: 2153-2160
- Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.Lancet Infect Dis. 2014; 14: 31-39
Article info
Publication history
Published online: December 03, 2014
Footnotes
Funding/support: This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, and Operational Research Unit, Medecins sans Frontieres, Brussels. The course was supported financially by an anonymous donor and the Department for International Development, UK.
Conflicts of interest: None declared.
Identification
Copyright
© 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
